Graphic Tuner

DNA Structure

Network & Extraction

Motion & Interaction

Wobble

Unify your clinical trials. Accelerate your studies.

The fastest growing Next-Gen, single clinical trial platform. Stop juggling disconnected vendors

Join 50+ forward-thinking clinical teams

Powering trials across leading research organizations

Lilly
Sanofi
AstraZeneca
Biogen
Zurabio
Olema Oncology

The hidden cost of your vendor stack

Fragmented systems don't just slow you down — they compound risk across every site, every visit, and every filing.

5+
Disconnected vendors per trial — eISF, eTMF, EDC, eSource, and CTMS that don't share data, each with separate logins, contracts, and validation cycles.
12 wks
Lost to deployment before first patient in. Legacy platforms require months of configuration, custom integrations, and UAT before a single form goes live.
3,200+
Manual queries per trial generated from data discrepancies between source and EDC — each one a reconciliation delay that inflates timelines.
We had five systems that didn't talk to each other. Our monitors were spending more time reconciling data than actually reviewing it. Every audit was a scramble to pull documents from three different platforms.
RS

VP, Clinical Operations

Mid-Stage CRO, Rare Disease

Replace your fragmented stack

Stop juggling disconnected vendors. Unify every clinical operation in one compliant platform.

Clincove Platform Architecture Clincove Platform Architecture
FDA 21 CFR Part 11
HIPAA Compliant
GDPR Compliant
GxP Validated

Every feature is built on a compliance-first foundation. Not an add-on—a prerequisite.

eISF & eTMF

Centralized document management with powerful viewer

Manage the full document lifecycle — from upload through eSignature — with real-time collaboration between sites and sponsors.

  • Built-in PDF viewer with annotation and markup tools
  • 21 CFR Part 11 compliant eSignatures
  • Version control with full document history and audit trail
  • Assign documents to team members with deadlines
  • Real-time sync between site and sponsor eTMF
Learn more about eISF & eTMF
Schedule of Activities
Filter columns by: In Progress Active Queries Ready For SDV Source Data Verified Form Signed
Visit / ActivityScreeningTreatment PeriodSafety
Visit Windows / DaysVisit 1Visit 2 / Day 1Visit 3 / Day 15 ± 3dVisit 4 / Day 29 ± 3dVisit 5 / Day 57 ± 3dVisit 8 / Day 141 ± 3d
Demographics
Eligibility Criteria
Medical History
Prior Beam Radiotherapy
Vital Signs
Clinical Laboratory Evaluations
Concomitant Medication
EDC & eSource

Modern data capture with built-in source verification

Capture and verify clinical data without switching between tabs, systems, or paper binders.

  • Side-by-side source document verification
  • Visit-based form navigation with real-time status tracking
  • Configurable edit checks and automated query generation
  • Keyboard shortcuts and minimap for efficient review
Learn more about EDC
Protocol AI

Navigate protocols with your AI expert

Ask questions about any protocol and get instant, cited answers — all within a closed ecosystem where no patient data leaves your tenant.

  • Every answer cites exact page numbers and sections
  • Side-by-side PDF viewer to verify source context instantly
  • Full audit trail on every query — built for GxP environments
  • Supports multi-protocol search across your entire library
Learn more about Protocol AI
1 8
/ 33
90%

Protocol number: CLT-NVX-2025-01

PROTOCOL INFORMATION FOR CANADIAN SITES ONLY

Clinical Trial Protocol 01

Version date: 24-MAR-2025

Protocol Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Neravex (CLT-105) in Adults with Generalized Anxiety Disorder (GAD)

Cover Page
SPONSOR ADDRESS

Clarion Therapeutics

123 Road St East

Toronto, Ontario, Canada

A1A 1A1

Medical Advisor

Sousa, Michael

Tel: +1-416-555-5555

Section 5.2

EXCLUSION CRITERIA

Subjects meeting any of the following criteria will be excluded from participation in this study:

1. Current diagnosis of Major Depressive Disorder (MDD) with active depressive episode within 6 months prior to screening
2. History of bipolar I or II disorder, schizophrenia, schizoaffective disorder, or other psychotic disorder
3. Active suicidal ideation as measured by a score ≥ 4 on the Columbia-Suicide Severity Rating Scale (C-SSRS) at screening
4. Known hypersensitivity or allergy to CLT-105 or any of its excipients
5. Use of prohibited medications including MAOIs, benzodiazepines, or other anxiolytics within 14 days of randomization
6. Clinically significant abnormalities on ECG, laboratory tests, or physical examination at screening
7. Pregnant or breastfeeding women, or women of childbearing potential not using adequate contraception

Your AI Protocol Expert

Welcome to the Protocol AI — your interactive guide to navigating your trial protocol. Ask questions and uncover insights quickly.

What are the exclusion criteria?

Based on Section 5.2 of the protocol, the key exclusion criteria are:

  • Current diagnosis of Major Depressive Disorder (MDD)
  • History of bipolar, schizophrenia, or psychotic disorders
  • Active suicidal ideation (C-SSRS score ≥ 4)
  • Known hypersensitivity to CLT-105
  • Use of prohibited medications (MAOIs, benzodiazepines) within 14 days

Referenced from page 8, Section 5.2

Ask anything... What are the exclusion criteria?

See the platform in action

Book a 30-minute walkthrough tailored to your trial design.

TRUSTED BY CLINICAL TEAMS WORLDWIDE

Measurable impact from day one

80%
Fewer data queries vs. legacy EDC
4 wks
Average time to first patient visit
60%
Reduction in vendor integration costs

Based on sponsor deployments across oncology, rare disease, and cardiology trials.

Real results from real trials

See how sponsors and CROs are consolidating their clinical operations into a single platform.

Clincove has been a reliable and responsive partner, helping us streamline clinical operations and improve workflow efficiency. Their support makes a real difference.
BB

CEO, Bobcat Bio

Oncology Clinical Trials

Oncology

Mid-stage CRO eliminates 4 vendor contracts and reduces deployment time by 70%

70% Faster deployment
4→1 Vendor consolidation
Read the full story
Rare Disease

Biotech sponsor achieves first patient visit in 3 weeks with protocol-first setup

3 wks To first patient
85% Fewer queries
Read the full story
Cardiology

Global pivotal trial goes live across 40 sites in under 6 weeks

40 Sites deployed
6 wks Full deployment
Read the full story
Free Tool

Plan your next trial — for free

Use our interactive trial planning tool to map out your study design, estimate timelines, and identify where Clincove fits into your operations. No signup required.

Estimate site count, visit schedule, and deployment timeline
Compare build-vs-buy costs with transparent ROI projections
Export a shareable summary for your team and stakeholders
Launch Trial Planner No account required. Takes 5 minutes.
plan.clincove.com
Study Phase Phase II
Therapeutic Area Oncology
Sites 24 sites
Est. Deployment 3.5 weeks
Est. Cost Savings $142K / year

Built for regulated environments

Every action in Clincove produces a complete audit trail. From electronic signatures to role-based access, compliance isn't an add-on — it's the foundation.

FDA 21 CFR Part 11

Compliant electronic signatures with full identity verification and authentication workflows.

HIPAA & GDPR

Enterprise-grade security and privacy controls protecting patient health information at every layer.

Complete Audit Trail

Every document, every data point, every action logged and traceable for inspection readiness.

Role-Based Access

Site-level permissions with granular controls for investigators, monitors, and sponsors.

AES-256 Encryption

Data encrypted at rest and in transit with TLS 1.3, ensuring end-to-end security.

Multi-Site Deployment

Deploy across sites globally with regional data residency and multi-language support.

Validated deployment in weeks, not months

Enterprise-grade setup with dedicated success teams at every step.

1

Protocol-first configuration

Upload your protocol document. Clincove AI generates your study binder, forms, visit schedule, and data validation rules — pre-configured for compliance.

2

GxP-validated environment

Your dedicated instance is provisioned with role-based access, audit trails, and electronic signatures — validated and ready for inspection from day one.

3

Guided site onboarding

Dedicated success team trains your sites with a single login. Average time from kickoff to first patient visit: 4 weeks.

Frequently asked questions

Everything you need to know about getting started with Clincove.

How long does deployment take?

Most sponsors are live within 2–4 weeks. Clincove's protocol-first approach means your study binder, forms, and visit schedule are auto-generated from your protocol document, dramatically reducing setup time compared to legacy platforms.

Can I migrate data from existing systems?

Yes, Clincove supports bulk data migration from legacy EDC, eISF, and eTMF systems. Our onboarding team handles the mapping, validation, and transfer so your team can focus on the science.

What compliance standards does Clincove meet?

Clincove is designed for regulated environments and meets FDA 21 CFR Part 11, HIPAA, GDPR, and ICH E6(R2) GCP guidelines. Every action produces a complete, inspection-ready audit trail.

How does pricing work?

Clincove offers per-study licensing with transparent, predictable pricing. No hidden platform fees, no per-user charges for site staff. Contact our team for a custom quote based on your trial portfolio.

Do you integrate with existing CTMS/IRT systems?

Yes, we offer REST APIs and pre-built connectors for common CTMS, IRT, and RTSM platforms. Clincove is designed to integrate into your existing ecosystem, not replace everything at once.

What training is required for site staff?

Clincove was designed for clinical teams who are not technology specialists. Most site staff are proficient within a single guided session. In-app help, contextual tooltips, and our support team ensure a smooth experience.

Have Questions?

Have questions about Clincove? We're here to help you find the right solution for your clinical trial needs.

Personalized platform walkthrough
Discuss your specific trial needs
No commitment required
FDA 21 CFR Part 11
HIPAA & GDPR compliant
You're subscribed!